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Tissue Engineering (TE), a subfield of Regenerative Medicine, arises as an attempt to repair 
diseases or defects by using cells, tissues and biomaterials isolated or in combination, to restore 
or improve biological functions. Cell sheet (CS) engineering is a TE cell-based technique that 
uses stimuli-responsive culture surfaces to fabricate robust and intact cell monolayers that can 
be implanted without requiring the support of a scaffold. The creation of viable thick CS 
constructs is limited by the lack of suitable vascularization strategies prior to implantation. The 
herein described strategy results from the optimization of different aspects of cell culture to 
obtain cell sheets capable of developing a capillary-like network in vitro without adding 
extrinsic growth factors. These cell sheets are derived from the isolation of the stromal vascular 
fraction (SVF) of adipose tissue, which is composed of different cell populations including 
stromal, endothelial and hematopoietic cells, holding thus an intrinsic angiogenic potential. The 
culture was performed with basal medium in normoxic (pO2 = 21%) and hypoxic (pO2 = 5%) 
conditions for up to 8 days. Cell proliferation results showed no significant differences between 
all conditions. Immunocytochemistry performed with the endothelial marker CD 31 and CD 146 
that stains pericytes demonstrated the organization of SVF cells in capillary-like structures for 
both conditions, although the level of branching was much more complex in hypoxia. It was 
hypothesized that the secretion of growth factors by cells was involved in this effect. A matrigel 
assay using conditioned media from the different conditions showed increased formation of 
capillary-like structures by endothelial cells cultured in hypoxic conditioned media. The same 
conditioned media increased the migration of human adipose stem cells (hASCs) in a scratch 
assay, when compared with media collected from normoxia. The production of growth factors 
assessed through ELISA suggested higher secretion of VEGF for hypoxia although statistical 
analysis showed no significant differences by comparison with normoxia. Western blot for HIF-
1α expression highlighted more prominent bands for hypoxic conditions. In vivo implantation 
of cell sheets cultured for 8 days in normoxia and hypoxia following a hind limb ischemia 
model showed improved neo-angiogenesis as evidenced by immunohistochemistry and laser 
Doppler. These results highlight the outstanding potential of combining hypoxic conditions and 
SVF cells to create cell sheets that can be used as functional vascularization units for TE and 
RM.  






A Engenharia de Tecidos (TE), uma subárea da Medicina Regenerativa (RM), surge como uma 
tentativa de reparar doenças ou defeitos usando células, tecidos e biomateriais, isoladamente ou 
em combinação, para restaurar ou melhorar funções biológicas. A Engenharia de Cell Sheet 
(CS) é uma técnica de TE baseada em células que usa superfícies de cultura sensíveis a 
estímulos de temperatura para fabricar monocamadas celulares intactas e robustas que podem 
ser implantadas sem requerer o apoio de um scaffold, evitando assim algumas das várias 
restrições às quais eles estão associados. A criação de estruturas de CS viáveis e espessas, 
necessárias para regenerar tecidos mais robustos como o osso, é limitada pela falta de 
estratégias de vascularização eficazes, antes da implantação. A falta de vascularização adequada 
resulta, muitas vezes, em necrose celular e rejeição da estrutura sendo, por isso, uma das 
maiores preocupações na área da TE. Na comunidade científica, diversas estratégias foram 
propostas neste sentido, muitas delas envolvendo o uso de células endoteliais que, embora 
bastante promissoras, enfrentam múltiplos desafios como sendo as fontes de células e a 
estabilidade dos novos vasos sanguíneos formados. A estratégia aqui descrita resulta de uma 
optimização dos diferentes aspectos relativos à cultura celular para obter CS capazes de 
desenvolver, in vitro, uma rede de estruturas semelhantes a capilares sem adição de factores de 
crescimento extrínsecos. Estas CS são derivadas do isolamento da fracção vascular estromal 
(SVF) do tecido adiposo após dissociação enzimática por acção da colagenase. Este tecido tem 
vindo a destacar-se na comunidade científica pelas suas características: é abundante, 
prescindível e pode ser facilmente obtido. Para além disso, a SVF é considerada como sendo 
detentora de um potencial angiogénico intrínseco, em virtude do tipo de células que a compõem. 
As células da SVF isoladas a partir de tecido proveniente de lipoaspirações foram distribuídas 
por placas estéreis de 24 poços numa densidade de 2x105 células nucleadas/poço e cultivadas 
em condições de normóxia (21%) e hipóxia (5% de oxigénio) com meio basal durante 8 dias. 
Foram efectuados diversos testes in vitro após terem sido atingidos os time points de 5 e 8 dias, 
nomeadamente citometria de fluxo (também efectuada imediatamente após o isolamento), 
quantificação de ADN, ensaios de matrigel e scratch, ELISA, imunocitoquímica e western blot. 
Para além disso, foram também efectuados ensaios in vivo após indução de isquemia nos 
membros posteriores que foram avaliados por imunohistoquímica, hibridização in situ e laser 
Doppler.  
A análise dos marcadores de superfície das células da SVF por citometria de fluxo evidenciou 
que a expressão dos marcadores endotelial CD 31 e hematopoiético CD 34 decresce ao longo do 
tempo, o que seria expectável uma vez que a cultura foi efectuada em meio basal, sem adição de 
factores de crescimento extrínsecos. Na literatura, a SVF do tecido adiposo é descrita como 
 
 
sendo composta por diversas populações de células, incluindo células estromais, endoteliais e 
hematopoiéticas, facto que foi comprovado nesta análise. Os resultados relativos à proliferação 
celular de células da SVF mostram que não há diferenças significativas entre as condições de 
normóxia e hipóxia sugerindo que a proliferação destas células não é afetada significativamente 
pelas concentrações de oxigénio. A imunocitoquímica realizada para os marcadores CD 31 e 
para o CD 146, o qual marca péricitos, demonstram a organização de células da SVF em 
estruturas tipo capilares para ambas as condições, embora o nível de ramificação tenha sido 
mais complexo em hipóxia para 8 dias. A comprovar este facto, a quantificação das estruturas 
tipo capilares no Angiogenesis Analyzer, um plug-in do programa Image J, destacou que as 
formações seriam mais maduras e organizadas nessas mesmas condições. Esse facto tornou-se 
mais evidente num dos dadores devido ao decréscimo no número de segmentos e malhas 
formados pelas células ao longo do tempo, sendo que o nível de ramificação se manteve 
praticamente inalterado. Isso traduziu-se em segmentos mais alongados e interconectados entre 
si. Foi levantada a hipótese de que a secreção de factores de crescimento pelas células em 
condições de hipóxia poderia estar envolvida neste efeito. Como tal, foram efectuados diversos 
ensaios utilizando os meios condicionados recolhidos das culturas em diferentes condições. Um 
ensaio de matrigel utilizando um extracto de membrana basal proteico que favorece a 
angiogénese, evidenciou um aumento na formação de estruturas tipo capilares pelas células 
endoteliais cultivadas em meio condicionado hipóxico. Os mesmos meios condicionados 
aumentaram a migração de células estaminais do tecido adiposo humano (hASCs) num ensaio 
scratch, quando comparados com os meios recolhidos de normóxia. O ensaio scratch é um 
ensaio baseado na raspagem da zona central de uma monocamada celular para avaliar a 
migração das células em torno da área erodida, sob diferentes condições. A produção de factores 
de crescimento avaliada por meio de ELISA sugeriu uma maior secreção do VEGF para 
condições de hipóxia. Colocou-se a hipótese que este facto poderia estar relacionado com a 
estabilização das subunidades dos HIFs (hypoxia inducible factors) em condições de 
concentrações baixas de oxigénio. OS HIFs são uma família de factores de transcrição 
constituída por três subunidades principais HIF-1, HIF-2 e HIF-3 e os seus respectivos 
heterodímeros (alfa e beta). As subunidades alfa respondem a variações na concentração de 
oxigénio e sob condições de oxigénio atmosféricas (normóxia) são constantemente expressas e 
degradadas no citoplasma, mais concretamente no proteassoma. Em condições de stress de 
oxigénio estas subunidades migram para o núcleo onde se ligam aos seus heterodímeros, os 
quais são constitutivamente expressos, e estabilizam. Esta estabilização resulta num aumento da 
secreção de diversos factores de crescimento responsáveis pela regulação do metabolismo da 
glucose, eritropoiese e angiogénese como sendo o VEGF e o PDGF. Deste modo, foi efectuada 
uma análise por western blot para o HIF-1α a qual destacou bandas mais proeminentes para 
condições de hipóxia. Paralelamente às condições de hipóxia e normóxia foram também 
 
 
testadas a incubação das células com um inibidor da subunidade HIF-1α e com cloreto de 
cobalto II, um indutor químico de condições de hipóxia. Como seria expectável, a banda obtida 
na análise de western blot para o inibidor foi bastante ténue contrariamente à obtida com o 
mimetizador das condições de hipóxia. Em imunocitoquímica isto reflectiu-se num fraco e 
proeminente desenvolvimento das estruturas tipo capilares, respectivamente, facto que veio 
reforçar a hipótese proposta.  
Finalmente, depois da manutenção das CS por 8 dias em condições de normóxia e hipóxia foi 
efectuada a sua implantação in vivo em ratinhos durante 33 dias, após indução de isquemia no 
membro posterior. A imunohistoquímica dos explantes recuperados executada para os 
marcadores endotelial CD 31 e perivascular α-SMA destacou uma melhoria na neo-angiogénese 
em condições de hipóxia por comparação com as de normóxia e controlos. Foi efectuado 
também um ensaio de hibridização in situ para localizar as células humanas nos explantes e 
verificou-se que algumas destas células permaneciam na área da implantação em torno dos 
novos vasos sanguíneos formados. Os resultados obtidos através do laser Doppler demonstram 
que a perfusão dos vasos sanguíneos aumentou nos animais em que foram transplantadas as cell 
sheets. Para além disso, foi observado que nos animais que receberam as cell sheets 
provenientes de culturas em hipóxia havia uma tendência para uma recuperação mais rápida do 
fluxo sanguíneo. Tendo em consideração todos os resultados obtidos é importante salientar o 
excelente potencial da estratégia aqui descrita que resulta da combinação de diversos conceitos 
como sendo, condições de hipóxia, células da SVF e Engenharia de Cell Sheet (CS) para criar 
unidades de vascularização funcionais para TE e RM. 
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The herein presented thesis is divided in four main chapters: chapter I, the state of the art of the 
theme; chapter II, the detailed description of all materials and techniques applied throughout the 
work; chapter III, the scientific paper written during this dissertation project that integrates all 
the results, discussion and final conclusions which, at the time of the delivery of this thesis was 
in process of submission, and finally chapter IV, the appendices. 
II.I. INTRODUCTION 
 
1. Tissue Engineering and Regenerative Medicine 
Tissue Engineering (TE) is a forefront area in Health Sciences whose purpose is to rebuild or 
repair damaged or aged cells, tissues or even entire organs by isolated or combined action of 
cells, growth factors and biomaterials. It is integrated in the field of Regenerative Medicine 
(RM) that aims the regeneration of tissues and organs using not only TE but also the potential of 
genetics and cell therapy. Cell-based approaches such as TE and cell therapy take advantage of 
the biological properties of mesenchymal stem/stromal cells, which can be found in almost all 
tissues of the human body, to regenerate tissues or entire organs by transplantation into the 
injured site. Most of TE strategies require a well-orchestrated sequence of events that range 
from the extraction of cells, which can be expanded or induced to differentiate upon 
administration of proper biochemical cues in cell culture surfaces, to its transplantation 
integrated in 3D scaffolds made of both natural and synthetic biomaterials, in the same patient. 
In order to be functional after implanted in vivo, these scaffolds should have some basic 
properties: they have to be biocompatible, bioresorbable with a well-controlled degradation rate 
and facilitate the diffusion of nutrients and oxygen through a porous surface. Besides, this 
surface should be compatible with cell attachment and constructs must possess specific 
mechanical properties taking into account the target-tissue[1]. However, biomaterials-based 
strategies face several constraints associated mainly with immunogenicity problems and poor 
degradation rate of the scaffold that can lead to fibrosis and necrosis in the bulk of thicker 






Figure 51- Traditional cell-based approach in TE. Adapted from: 
http://www.wikilectures.eu/index.php/Tissue_engineering_principle  
 
Another constraint typically associated with cell-based strategies is cell sourcing. Mesenchymal 
stem cells, also known as multipotent stromal cells, captivated an overwhelming attention in the 
scientific world as powerful therapeutic tools and inspired several works, a great part of them 
using MSCs isolated from the bone marrow. The first pioneer works reporting the discovery of 
a MSC’s niche date back to 1968 when Friedenstein and colleagues discovered that stem cells, 
derived from the bone marrow (BMSCs), were capable of differentiating into bone [3]. 
However, the extraction of cells from the bone marrow is often associated with donor-site 
morbidity, pain and poor yield of cells. Necessity of an alternative spurred scientists to find new 
MSC sources and currently it is well known that they can be found in almost all tissues of the 
human body, namely skeletal muscle [4], adipose tissue [5], skin [6], pancreas [7], synovial 
membrane [8], dental pulp [9], placenta[10], trachea [11], nasal mucosa[12], Wharton’s jelly 
[13]  and also amniotic fluid[14], menstrual blood[15], among others.  
There are a lot of studies in clinical trials regarding cell-based strategies involving mainly the 
use of stem cells isolated from bone marrow, adipose tissue, placenta and umbilical cord blood 
for several different applications. Amongst this wide range of applications it’s possible to find 
immunological and blood diseases, cardiac repair and neurological disorders[16]. 
 
2. The problem of Vascularization after implantation 
Blood vessels, major components of the circulatory system, are essential for the survival of the 
tissues and organs by supplying the nutrients and oxygen and collecting the waste products from 





neovascularization is a critical aspect for the effective survival of tissue engineered constructs in 
order to avoid hypoxia and/or anoxia in the inner mass of tissue-engineered constructs, due to a 
poor diffusion of nutrients and oxygen essential for their successful engraftment. Ultimately, 
this poor supply of nutrients and oxygen can culminate in unsatisfactory tissue regeneration or 
even, failure of the construct. Nonetheless, is difficult to build whole prevascularized implants 
that could mimic tissues and organs thickness without compromising the distance between cells 
and blood vessels.  
Neovascularization comprises three distinct processes: vasculogenesis, angiogenesis and 
arteriogenesis. Vasculogenesis corresponds to the process by which de novo vessels are formed 
during the embryonic phase by endothelial progenitors[17] developing a primitive vascular 
plexus. The sprouting and stabilization processes that follow vasculogenesis and the reshuffle of 
the early vasculature into a complex and functional circuit are called angiogenesis and 
arteriogenesis. For that purpose, the secretion of diverse angiogenic growth factors and 
recruitment of mural cells like smooth muscle cells and pericytes are required to promote ECs 
survival, proliferation and differentiation as well as the complexity of the blood vessels[18]. 
Vascular endothelial growth factor (VEGF), angiopoietin (ANG), platelet-derived growth factor 
(PDGF), fibroblast growth factor (FGF), TIMP (tissue inhibitor of metalloproteinases), 
transforming growth factor (TGF-α) and (TGF-β), hepatocyte growth factor (HGF), tumor 
necrosis factor-α (TNF- α), proteins, cytokines are also known for playing an active role in the 
process of neovascularization[17]. VEGF is crucial for modulating endothelial progenitor cells 
(EPCs) behavior [19] and endothelial cells (ECs) survival, inducing a powerful angiogenic 
response for both neovascularization and pathological conditions[20]. Moreover, stabilization 
and maturation of primary capillary plexus depends on the coordinated action of PDGF, TIMP 
(by remodeling of the ECM during the sprouting),  TGF-β and FGF (angiogenic promoters 




    
 
Figure 62 - Formation of blood vessels is regulated by three fundamental processes: vasculogenesis (during the 
embryo development), angiogenesis and arteriogenesis. Adapted from [21]. 
 
Several strategies mainly related with in vitro and in vivo prevascularized engineered constructs, 
which can involve angiogenic factors or scaffolds, are under investigation, many of them 
reporting the use of endothelial cells [22–25]. For instance, transplantation of ex vivo expanded 
human endothelial cells was found to increase the blood vessels and capillary perfusion in a 
hind limb ischemia induced in mice by Kalka et. al[23]. The same type of cells expanded also 
ex vivo were used as a therapeutic tool in myocardial ischemia[25]. Co-culturing endothelial 
cells with bone marrow derived stem cells promoted vascularization after implantation[26,27]. 
Nevertheless, the previously described strategies reported fairly late blood vessels formation. 
Scaffolds have been also widely used to support the formation of blood vessels. For instance 
Santos et. al engineered a cell-based construct using a blend of starch with polycaprolactone and 
co-cultures of endothelial cells and osteoblasts for bone tissue regeneration. The culture in the 
first 21 days lead to the formation of microcapillary-like structures, more branched and 
developed after 35 days[28]. Osteogenic/vasculogenic constructs based on porous 
hydroxyapatite scaffolds and SVF cells cultured in vitro for 5 days were found to form blood 
vessels and bone tissue 8 weeks post-transplantation in nude mice[29]. Moreover, spheroid co-
cultures of endothelial and osteoprogenitor cells resulted in the formation of prevascularized 
networks of capillary-like structures 10 days after in vitro culture for bone tissue engineering 
applications. However, integration with host vasculature after implantation of the construct was 
found to be poor[30]. The controlled release of angiogenic factors, in the case bFGF, has been 
achieved by incorporating microspheres composed of poly (lactic-co-glycolic acid) on alginate 





peritoneum[31]. Nano-sustained controlled release of VEGF on polylactic acid microspheres in 
combination with SVF cells increased also capillary density in nude mice, 2 months after 
implantation[32]. The potential of SVF cells in a process of tissue expansion in rats was found 
to be facilitated, possibly due to the secretion of EGF, VEGF and bFG which increased not only 
blood vessels formation but also cells proliferation[33]. Recently, SVF cells were used as 
vascularization tools in the generation of a human liver. Co-culturing SVF cells with HepG2 
cells resulted in the integration of the first with the host vasculature and in an interactive role 
with parenchymal cells[34]. Endothelial cells were also used to promote vascularization for 
regeneration of other tissues such as skin[35] or skeletal muscle[36]. Nevertheless, most of the 
described strategies have drawbacks such as the late formation of blood vessels in vitro and/or 
post-implantation, the complexity associated with cultures of more than one cell type isolated 
from different tissues and formation of fibrous tissue after implantation of engineered 
constructs. With the exponential growth of the engraftment technology over time there is an 
increasing need to find more, faster and efficient techniques for neovascularization.  
 
3. Stromal Vascular Fraction derived cells 
Adipose tissue was neglected in previous years in the scientific world because it was seen as an 
organ exclusively associated with the storage and release of lipids. Nonetheless, their unique 
properties (accessibility, low-cost and abundance) combined with the fact of being a reservoir of 
stem and stromal cells made it quite captivating as a cell source [5]. Also, as fat tissue lines and 
protects several parts of the human body it can be easily identified, namely at the intra-
abdominal area and subcutaneously, and extracted through minimally invasive procedures. 
As stated by the International Society for Cellular Therapy the definition of multipotent 
mesenchymal stromal cells, typically named mesenchymal stem cells, can be divided in three 
fundamental topics: the presence or absence of selected surface markers (they must express 
specific cell surface antigens such as CD73, CD90, and CD105, and lack expression of other 
markers including CD45, CD34, CD14, CD11b, CD79α, or CD19 and HLA-DR surface 
molecules) and adhesion and multipotency in vitro (MSCs must be adherent to plastic when 
kept under standard culture conditions and have the capacity to differentiate in vitro into 
osteoblasts, adipocytes, and chondroblasts) [37]. Besides these three fundamental topics, 
mesenchymal stem cells can also be easily identified by their functional properties: the self-






The initial works regarding the isolation of stem and stromal cells from the adipose tissue were 
developed in the 60s by Rodbell et al. in rat fat pads. Briefly, Rodbell et al. chopped the fat and 
then washed it several times in order to remove unwanted cells. The extracellular matrix (ECM) 
of the remaining tissue was then digested with collagenase and centrifuged for deposition of 
stromal vascular fraction (SVF) cells. Then, SVF cells were removed by aspiration and fat cells 
washed. This process of isolation is very similar to the one that is used now, with human 
lipoaspirate tissues with the addition of a red blood cells lysis buffer to the equation. 
Nevertheless, literature already describes non-enzymatic methods for SVF isolation [38].  
 
Figure 73 - Isolation and potential applications of human adipose tissue derived stem cells. Adapted from [39]. 
 
Adipose-derived stem and stromal cells are multi and pluripotent cells, respectively, that result 
from the processing of fat tissue. Cells from the stroma of adipose tissue are quite 
heterogeneous among themselves since they constitute a cocktail of different populations such 
as pre-adipocytes, mesenchymal progenitors, fibroblasts, pericytes endothelial and 
hematopoietic cells [40–42]. This heterogeneous composition makes them ideal candidates for a 








3. The intrinsic angiogenic potential of SVF derived cells 
Stromal vascular fraction from adipose tissue has been recently regarded as highly angiogenic 
and, therefore, quite captivating for improvement of the neovascularization. These cells are 
known to promote the formation of capillary-like structures both in vitro and after 
transplantation.  
Besides its hematopoietic and endothelial composition others factors have been pointed as 
conditioning for the angiogenic potential of SVF cells. Koh et al. hypothesized that the network 
of capillary-like structures they are capable to build is created by the reassembly of endothelial 
progenitors and mural cells contained in the SVF mixture [43]. Dong et Al. also hypothesized 
that the recruitment of M2 macrophages may also constitute one important factor influencing 
this angiogenic potential of SVF [44]. All of the research involving its angiogenic capacity 
made SVF cells quite attractive not only for in vitro but also for in vivo tests. For instance, the 
transplantation of the stromal vascular fraction from adipose tissue following a murine hind 
limb ischemia model have also been shown to promote neovascularization  [45,46]. The 
transplantation was also successful and resulted in the same angiogenic effects in random skin 
flaps[47]. The great ability of these cells to promote angiogenesis has contributed to 
physiological and pathological wound healing in mice. The same work  also highlighted the 
potential ability of these cells to enhance reepithelialization[48]. A 3D implant using freshly 
isolated SVF cells was also built for generation of a functional liver tissue [34]. Nevertheless, 
more studies need to be developed regarding the process by which SVF cells assemble as 
capillary-like structures and all variables involved in the process. 
 
4. Cell Sheet Technology 
To overcome some of the problems arising from previous cell-based approaches, namely the 
low anchorage of cells at the injured site [49] and the limitations related to the use of 
biomaterials as scaffolds [50], the concept of Cell Sheet Engineering was proposed in 1993, 
bringing a new approach  to tissue engineering: the recovery of a contiguous cell layer as a sheet 







4.1 The principle for cell sheet detachment 
The basic idea of Prof. Okano’s group was to develop a scaffold-free approach by coating 
culture surfaces through covalent grafting with a temperature-responsive polymer - poly(N-
isopropyl acrylamide) (PNIPAM) that transits from a dehydrated to a hydrated state at 
temperatures below 32º C. Thus, PNIPAM is regarded as being hydrophobic at temperatures 
above 32º C and hydrophilic below these. The group successfully cultured bovine endothelial 
cells and rat hepatocytes at 37º C until achieving confluence and then, by decreasing the 
temperature until approximately 20ºC, the interactions with the ECM were diminished. The 
critical value of temperature allowed a spontaneous cell detachment [51].   
 
Figure 84 - Cells recovery. Cells can be recovered as single cell suspensions by using proteolytic enzymes that 
degrade the cell-cell and cell-matrix interactions (upper right) or as cells sheets prepared using a temperature-
responsive polymer covalently grafted to a culture dish surface (lower right). 
 
This came to revolutionize the field, as cell sheet engineering (CSE) avoids the use of 
proteolytic enzymes such as trypsin and dispase, and the native ECM acts as a natural scaffold 
[52].  Nevertheless, besides these enzymatic treatments and declines of temperature, several 
other stimuli have been used for cell sheet detachment. Guillaume-Gentil et. al described a 
technique to obtain viable cell sheets composed of human placenta-derived mesenchymal stem 
cells based on a electrochemical induction of pH decrease [53]. The same group also described a 
technique based on polyelectrolyte thin films [54]. Many works using a wide range of different 
cell types described cell sheet detachments by using magnetic stimuli [55–60]. Through 
alternation of layer-by-layer depositions of polyanions and polycations, Zahn et. al described an 
ion-induced cell sheet detachment technique using myoblasts [61]. Micropatterning of the cell 





strategy [62–64]. This technique takes advantage of the critical temperatures of two different 
polymers for specific cell adhesion. 
4.2 Applications in the Regenerative Field 
The potential of cell sheet engineering has been extensively explored over the past few years 
and now this technology is proposed to improve and treat functions of many tissues such as 
periodontium [65–67], corneal epithelial [68,69], hepatic [70], urothelial [71,72] and renal [73] 
tissues, myocardium [74–79], thyroid gland [80], retinal pigment epithelium [81], lung [82,83] 
and pancreatic islet [84,85]. Besides, cell sheet engineering has been also proposed for 
esophagus [86–88] and cartilage tissues [89–91]. Our lab, has proposed also the use of CSE to 
engineer tissues such as skin [92] and bone [93].  
Cell sheet engineering has been applied also to improve neovascularization. Asawaka et. al have 
shown that by stacking human umbilical vein endothelial cells and normal human dermal 
fibroblasts is possible to build 3D stratified tissues to promote a pre-vascular network both in 
vitro and in vivo [94]. Co-cultures involving endothelial cells  resulted in increased 
neovascularization potential and improved cardiac function on ischemic hearts by using tissue-
engineered cardiomyocyte sheets [95]. Moreover, monolayered mesenchymal stem cell sheets 
were found to promote angiogenesis by paracrine pathways on infarcted myocardium [96]. 
Recent studies have also demonstrated the great ability of this technique to build functional 
vascularized 3D tissues for cardiac tissue [97]. 
Cell sheet engineering is also on clinical trials for myocardium - through transplantation of 3-
week-cultivated autologous myoblast cell sheets into patients[98] -, cornea - which commonly 
presents great outcomes[68] -, esophagus[99], periodontium - by using periodontal ligament cell 
sheets[66] - and cartilage tissues[100]. Nevertheless, literature does not describe yet the use of 
cell sheet engineering in combination with the whole SVF of adipose tissue. 
 
5. Hypoxia the “physiological normoxia” 
Oxygen is a critical component regarding stem and stromal cells culture that is quite often 
overlooked in the lab context. Since the very beginning of life, the irregularities experienced 
regarding the oxygen atmospheric concentrations have been boosting the evolution of 
eukaryotic species in an oxygen-dependent manner. It is believed that there must be a balance 
between the cellular need for O2 as a final acceptor of electrons during Krebs cycle and the 
production of ROS (reactive oxygen species) which lead to oxidative damage and can even 




[101] which are known for being much lower that the regular 21% O2 atmospheric levels. These 
lower oxygen levels, in comparison with the atmospheric ones, are called hypoxia. However, as  
 
in vivo physiological oxygen levels are considerably lower than the atmospheric values as cells 
reside in hypoxic niches this low oxygen tensions are often referenced as “normoxic in 
situ”[101]. 
  
5.1 Stem Cells Niche 
The stem cell niche can be defined as the microenvironment where stem cells reside. This 
microenvironment is composed of several components that regulate and control the stem cells 
fate by sustaining their needs and giving strong cues to direct their activity.  
Since the very beginning, during the embryonic phase, O2 concentrations are constantly varying 
from the 1-2% when the blastocyst is being implanted [102], rising to the 2-3% with a fully-
developed circulatory system  and achieving the regular O2 values within the tissues at the 12-
13th week of gestation [103].  
 
In adults, O2 concentrations within the tissues are dependent on the surrounding blood vessels 
vascularization but they are considerably lower than the ambient O2 concentration. Oxygen 
values in the circulation typically range from 4% to 14% [104], similar to what happens in other 
organs such as liver [101,105], kidneys [101,106] and lung parenchima [101,107]. In the brain, 
the oxygen concentrations can be so low as 0.5% being capable to go up until 8% [108]. The 
oxygen levels in the eye [109] and in the bone marrow [110] range from 1 to 5 and 6%, 
respectively. In the adipose tissue these concentrations are found to be typically between 2 and 
8% [111]. 
 
5.2 Hypoxia Inducible Factors: the signaling cascade 
Hypoxia-inducible factors (HIFs) are a family of transcription factors responsible for regulating 
homeostasis, by controlling cellular responses, under low oxygen tensions. The HIF family is 
composed by three fundamental subunits, HIF-1, HIF-2, and HIF-3, and its corresponding 
heterodimers (alpha and beta). Alpha subunits are oxygen responsive and become stable in low 
oxygen conditions by binding their corresponding beta subunits in the nucleus or even in the 
presence of iron chelators [112]. At regular oxygen conditions, the so called normoxia, these 




subunits, also known as aryl hydrocarbon receptor nuclear translocators (ARNTs), are 
constitutively expressed in both conditions.  
HIFs are known for playing a critical role in a wide range of pathological conditions with a 
special focus in cancer and ischemic diseases. There is evidence in the literature that many 
tumors propel strongly hypoxic environments that correlate with the progression of the disease 
by promoting cell invasion and proliferation, angiogenesis and metastasis [113]. This might be 
due to the fact that HIFs expression triggers the induction of several crucial genes for glycolysis 
(glucose transporters and glycolytic enzymes) and formation and maturation of the blood 
vessels such as VEGF, erythropoietin, angiopoietin and platelet-derived growth factor. The 
latter also highlights why HIFs can be so promising for preventing or even treating ischemic 
affected areas [113]. For that, understanding HIFs pathway and the role that each specific 
subunit plays in oxygen deprived conditions is currently the subject of several studies. By now, 
it is well accepted that all subunits share diverse similarities especially regarding HIF-1α and 
HIF-2α, while HIF-3α is thought to have an opposite effect under hypoxic conditions. The basic 
mechanism in the signaling pathway of HIF-1 and HIF-2 at regular O2 concentrations involves 
prolyl-hydroxylases that enzymatically induce HIF alpha subunits to bind to von Hippel Lindau 
(VHL) protein by altering their conformation. The action of the prolyl-hydroxylases occurs in 
different prolines according to the subunit, hydroxylating them in their respective oxygen-
dependent degradation domains (ODD). The lack of O2 in hypoxic conditions leads to an 
accumulation of the alpha subunits that translocate to the nucleus, where they bind to their 
respective ARNT subunit. The transcription of several genes is then activated through the bind 





Figure 95 - HIF pathway for both normoxic and hypoxic conditions. Adapted from:  
http://being-bioreactive.com/2014/06/27/focus-on-the-hypoxia-pathway/ 
 
Both subunits are also distinctive namely by their location, degree of induction controlled by O2 
concentration and functionality. While HIF-2α expression appears to be induced by extremely 
low levels of oxygen and triggered exclusively in endothelial cells and vascularized tissues, 
HIF-1α is thought to be expressed in all types of cells in mammalian at higher levels of oxygen 
concentration [113,117]. 
5.3 The impact of low physiological oxygen tensions 
Hypoxia has been widely used in the past few years for research purposes in cell culture. 
However, the way it affects cell behavior is not yet fully understood or can be even quite 
controversial. These cultures in low O2 environments have been studied for a long period of 
time, since 1972 when Allan Richter and his colleagues discovered that culturing cells in 
hypoxic conditions could help improving the platting efficiency by increasing the amount of 
cells that adhered to a plastic dish [118].  
 
Oxygen concentrations of 1 % have been shown to be promoters of the osteogenic 
differentiation in bone marrow mesenchymal stem cells [119]. Pre-culturing human ASCs at 5% 
O2 concentrations promotes the great ability of these cells to differentiate towards the 
chondrogenic lineages [120]. Hypoxic conditions of 2% O2 increases also the potential to 
differentiate into the adipogenic and  osteogenic lineages on the same type of cells [121]. 
Moreover, regarding the stemness and proliferation in the same severe hypoxic conditions, 




normoxic. Nevertheless, regarding differentiation, these stress oxygen conditions reduced the 
capacity of ASCs to differentiate into the adipogenic and osteogenic lineages enhancing the 
chondrogenic one [122]. Hypoxia pre-conditioning enhanced the survival of hASCs and 
influenced the behavior of endothelial cells in vitro [123] besides increasing the wound-healing 
potential of ASCs [124].  
 
Several researchers have also studied the angiogenic potential of hASCs in hypoxic conditions. 
Severe hypoxia increased the angiogenic paracrine activity of hASCs by increasing the 
production of VEGF-A and ANG [125]. Long-term hypoxia has been shown to improve the 
pro-angiogenic potential of hASCs [126]. The addition of growth factors to the culture of 
stromal cells derived from the adipose tissue is thought to produce the same effect [127]. 
Nevertheless, there are only a few studies regarding the effects of hypoxia in the whole SVF 








III.II. MATERIALS AND METHODS 
 
1. CULTURE OF SVF CELLS 
 
1.1 Isolation of human adipose stromal cells 
In collaboration with Hospital da Prelada, Porto (supplier of lipoaspirate tissues). 
  
Human adipose stromal cells were isolated and collected from subcutaneous fat tissue obtained 
through liposuction after informed consent of the patients (n = 3), in the scope of an agreement 
with Hospital da Prelada, Porto, after approval by the ethical committees of both institutions.  
 Firstly, adipose tissue, processed until 24h after collection, was washed extensively with 
a great amount of a phosphate-buffered saline solution (PBS) (Sigma Aldrich, USA), 
and two phases were clearly noticed: an adipose fraction on the top and an aqueous one 
containing blood, which deposited on the bottom and was removed, by pipetting.  
 Tissue digestion was then induced by incubating the adipose fraction (1:1) with a 
solution of PBS containing 0.05% of collagenase type II (Sigma Aldrich, USA) at 37ºC 
for at least 30 minutes and up to 45 minutes, under agitation, until the tissue was 
sufficiently loose.  
 Digested tissue was cleaned of any remnants of connective tissue and blood vessels by 
percolating it with a nylon mesh strainer with the assistance of forceps, followed by a 
centrifugation at 4 ºC, 800 g for 10 minutes.  
 After that period of time, supernatant was discarded and the obtained SVF was 
incubated with a red blood cells lysis buffer (154 mM of ammonium chloride, 10 mM 
of potassium bicarbonate and 0.1 mM of ethylenediaminetetraacetic acid – all from 
Sigma Aldrich, USA – in distilled water) for 10 minutes at room temperature to lyse 
undesirable erythrocytes.  
 In order to restore the osmotic equilibrium, α – MEM medium (Life Technologies, 
United Kingdom) supplemented with 10% FBS (Life Technologies, United Kingdom) 
and 1% antibiotic/antimycotic (Life Technologies, United Kingdom) was added and the 
obtained mixture was centrifuged for 5 minutes at room temperature at 300 g.  
 Lastly, red blood cells-free SVF was resuspended in α – MEM medium (Life 
Technologies, United Kingdom) supplemented with 10% FBS (Life Technologies, 
United Kingdom) and 1% antibiotic/antimycotic (Life Technologies, United Kingdom) 




 To perform an accurate cell counting distinguishing nucleated cells from any remaining 
erythrocytes and debris , 20 µl of cell suspension were incubated with 180 µl of a  
 
solution containing 3% acetic acid (VWR, United Kingdom) in methylene blue 0.05 wt. % 
in H2O (Sigma Aldrich, USA). Finally, 2x105 cells were distributed for each well of 15.6 
mm diameter 24-well culture sterile plates.  
  
1.2 Conditions of culture 
 
 Conditions of 21% (normoxia) and 5% of oxygen (hypoxia) were provided to the 
cultures. Low oxygen conditions were induced in a hypoxia modular incubator chamber 
(MIC-101, Billups-Rothenberg, USA) which was flushed for 6 minutes with a mixture 
of 5% O2, 5% CO2 and 90% N2, according to manufacturer’s instructions every day 
zero, one and five of culture.   
 The chamber was then placed in an incubator (Galaxy CO-170S, New Brunswick) at 
37ºC, 5% CO2 and cells were cultured up to 8 days.  
 After 5 and 8 days of culture, conditioned medium (for ELISA, matrigel and scratch 
assays) and cells were collected for posterior characterization.  
 
For matrigel and scratch assays, human dermal microvascular endothelial cells (HDMECs) and 
hASCs (passage 1-3) were used. A homogeneous culture of hASCs was obtained after the first 
passage of cells from the SVF since the remaining populations that it contains are lost during 
the culture process. The process by which cells are detached from the culture surface, changing 
their passage, happens when they reach approximately 90% of their confluence (percentage of 
space occupied by cells in the culture surface). 
  
 Briefly, after removing the culture medium cells were washed with PBS and then 
incubated with trypLETM Express (Life Technologies, USA) at 37º C for 10 minutes in 
the humidified incubator chamber.  
 After 10 minutes, cells detachment was confirmed on the microscope. The α-MEM 
medium was added and detached cells were centrifuged at 300g for 5 minutes.  










Cells cryopreservation is very useful for preserving cells at very low temperatures (-196º C) in 
liquid nitrogen. Enzymes and biomolecules remain in an inactive state for long periods of time  
 
 
allowing cells to maintain a viable state and be subsequently thawed without losing its 
properties.  
 
 Firstly, cells were detached from the well by incubation with trypLETM Express X at 37º 
C for 10 minutes and then resuspended in α-MEM medium.  
 After a centrifugation to obtain the pellet, cells were resuspended in a solution 
containing 10% of DMSO (Amresco, USA) in FBS (Life Technologies, United 
Kingdom) and distributed by cryovials (1 million of cells per each).  
 The following step, the freezing, was processed slowly to avoid formation of ice 
crystals: first cells were placed at -20 ° C, then at -80 ° C and finally in liquid nitrogen 
at -196º C. 
 
 
2. IN VITRO CHARACTERIZATION TESTS 
2.1 Flow Cytometry 
 
Flow cytometry is a technique used to perform measurements and/or analyze multiple 
characteristics of cells or particles (cell types in heterogeneous populations, cell surface 
expression and intracellular molecules, inter alia), as they pass through a laser beam. At that 
time, light will be scattered and then detected in the form of forward scatter (FS) or side scatter 
(SS) by appropriate detectors for the purpose. Forward scatter is cell size dependent while side 
scatter correlates with cellular content. In order to underline, through staining, certain 
characteristics of the cells, fluorochromes are commonly used. Each fluorochrome, which is 
connected to an antibody, retains its own emission wavelength, which in turn is going to be 
excited by the laser with the matching excitation wavelength. Then, by using a wide group of 
filters and mirrors is possible to steer the light (FS and SS) into defined wavelengths which are 
going to be captured by different detectors. 
 
As stated by the Mesenchymal and Tissue Stem Cell Committee of the International Society for 




positive expression of surface markers CD105, CD73 and CD90, and lack expression of CD45, 
CD34, among other surface molecules. However, as a SVF is rich in various nucleated cells 
(adipocytes, blood cells, and others) it is slightly positive for the hematopoietic surface markers 
CD34, CD45, and CD31. Thus, after performing a gating strategy with DRAQ5 to discern only  
 
 
 nucleated cells in the SVF, tested markers were CD105 - FITC, CD73 - PE, CD90 - APC, 
CD45 - FITC, CD34 - PE and CD31 - APC (BD Biosciences, Germany). 
 
Flow cytometry analysis were conducted at day zero, five and eight for each donor as it follows, 
 2 μl of each fluorochrome-conjugated antibody, mentioned previously, and 100 μl of sample 
(containing 1x105 cells) were added to each cytometer tube.  
 Tubes were then vortexed and left for incubation in the dark during 20 minutes at room 
temperature.  
 After that period of time, SVF cells and fluorochrome-conjugated antibodies were washed 
thoroughly with PBS and centrifuged at 350g, room temperature for 5 minutes. 
 Deposited SVF cells were then resuspended in acquisition buffer, PBS with 1% of 
formaldehyde (Sigma, USA), and data was then acquired subsequently in a FACSCalibur 
flow cytometer (BD Biosciences, Belgium) and analyzed using Cyflogic version 1.2.1 
(CyFlo Ltd, Finland).  
 
2.2 DNA Quantification on lysed cells 
 
The selected method to quantify DNA in lysed cells (in this case lysed by distilled water and 
frozen) involves the use of a fluorescent dye - PicoGreen – contained  in a kit (Life 
Technologies, USA) according to manufacturer’s instructions. When bound to dsDNA 
PicoGreen enhances its fluorescent intensity in accordance with the amount of DNA present in 
the sample. Thereby, it is often used to determine average dsDNA concentrations of a sample.  
 
The principle of this method is to use a set of samples with known concentrations (standards) to 
enable an estimate (by comparison) of the fluorescence of the unknown concentrations. 
Therefore, knowing the concentrations of these standards and by reading their fluorescent 
intensity it is possible to obtain a calibration curve, from which, values of concentrations are 





 Standards with concentrations of 0, 0.0018, 0.023, 0.289 and 3,614 μg/ml were prepared by 
making serial dilutions of the λ DNA in TE 1x which was in turn diluted in ultra-pure water.  
 To each well of a 96 well-plate, 100 μl of sample or standard plus 100 μl of the solution 
1xTE plus Picogreen reagent were added. It is noteworthy that 3 replicates were made for 
each value of concentration for standards and for each condition of the samples. 
 
 
 The fluorescent intensity was read at 485/528 nm using a microplate reader (SYNERGY 
HT, BIO-TEK, USA). 
 
2.3 Matrigel Assay 
The matrigel assay is a simple tube formation technique to evaluate the capability of vascular 
endothelial cells to assemble into capillary-like structures by embedding them in a basement 
membrane murine extract that mimics the extracellular matrix upon certain conditions.   
 The formation of capillary-like structures was assessed by embedding human dermal 
microvascular endothelial cells (HDMECs) in a basement membrane extract, Matrigel 
(Corning, USA). This heterogeneous extract presents a liquid form at 4 °C while at 
temperatures between 16 and 37°C proteins polymerize solidifying it as a gel.  
 The liquid Matrigel was casted into 96 sterile well-plates (32 µl per plate) for 30 
minutes at 37ºC, 5% CO2 in a humidified incubator chamber.  
 Immediately after, HDMECs at passage 2 in the respective conditioned mediums were 
seeded into each well in a density of 1.5 x104/per well and were then placed in the 
incubator at 37ºC for 24h.  
 Cells were then stained with calcein-AM (Life Technologies, USA) and visualized 
under an Axio Observer inverted Microscope with incubation (Zeiss, Germany). 
 
2.4 Scratch Assay 
The scratch assay is a widely accepted method in the scientific community to evaluate cell 
migration rate in vitro. The principle of this technique involves the creation of a "acellular 
break" in a cell monolayer (through cell removal by scraping the central area of the bottom of 
the well or by placing a tissue culture insert, which blocks cell growth only in a central space 
flanked by cells). 
 Recovered conditioned mediums for both conditions of biological samples used for in 




 Tissue culture inserts (ibidi, Germany) were attached to the middle of each well of 24 
sterile well-plates and 70 µl of cell suspension containing 3,5 x 104 hASCs/well in α-
MEM medium were added to each side of the insert.  
 After 24h, cells were in confluent layer and, for that, the insert was removed and all α-
MEM mediums were exchanged for the corresponding conditioned ones.  
 
 Cell migration was monitored by capturing images in an Axio Observer Inverted 
Microscope with Incubation (Zeiss, Germany) every 5 minutes for 24 hours. The 
obtained images were acquired and processed with Zen 2012 software (Zeiss, 
Germany). 
 
2.5 ELISA (Enzyme-Linked Immunosorbent Assay) 
ELISA (Enzyme-linked Immunosorbent Assay) uses the sandwich principle (antibody-antigen-
antibody binding) for colorimetric detection of specific proteins, hormones or other antigens. It 
can be very useful for measurements of antigen or antibody concentrations. To investigate the 
angiogenic potential of SVF CS the secretion of VEGF, FGF and PDGF-BB was quantified. 
Moreover, TIMP1 production was also quantified due to its essential role on promoting 
proliferation and anti-apoptotic functions in SVF CS. The assay was performed with mini 
ELISA Developments Kits (Peprotech, USA). 
 Briefly, the surface of 96 sterile well-plates was coated overnight with a capture 
antibody followed by a 1h blockage of the unspecific bonds with BSA 1% (Sigma, 
USA).  
 All steps in this test were interleaved with several washes.  
 Conditioned mediums recovered from SVF cultures of all donors (n=3) were added to 
the wells (100 µl) for 2h.  
 Antibody-antigen complex was then entrapped by a biotinylated antibody (2h of 
incubation) which in turn reacted with an avidin-horseradish peroxidase (avidin-hrp) 
conjugate that was allowed to attach biotin during 30 minutes.  
 100 µl of ABTS (Sigma, USA), the chromogenic substrate for the enzyme, which 
changes the intensity of the color in accordance with the amount of antigen present in 
the standard or sample, were added to the wells.  
 The color development was then monitored every 5 minutes until 30 minutes in a 
microplate reader (SYNERGY HT, BioTek) and the absorbance was read at 405 nm 
with a wavelength correction at 650 nm.  




Immunocytochemistry and immunohistochemistry (see point 2.12) share the same principle but 
while the first one is exclusively performed on cells the last one is performed in tissues.  
Both procedures are commonly used for detecting the expression of certain target proteins in 
cells or tissues by incubating them with a specific primary antibody, which will bind to it. Then,  
 
by adding a secondary antibody specific to the primary it is possible to highlight the outcomes 
of interest.  
2.7 Immunocytochemistry 
The procedure was executed as it follows:  
 Immediately after each time point, SVF cells were fixed in 10% formalin (Thermo 
Scientific, USA) for 30 minutes. After that, cells were washed with PBS. 
 Firstly, cells were incubated with Triton X-100 (0.2 % solution in PBS) (Sigma, USA), 
a detergent capable of improving antibody’s penetration, since the target protein is 
expressed intracellularly, for 10 minutes. Then, cells were washed with PBS (3 times).  
 In order to block unspecific binding of antibodies, an incubation of 30 minutes with 3% 
BSA (Sigma, USA)  in PBS was performed followed by an overnight incubation with 
the rabbit anti human-mouse CD31 (1:50) and mouse anti human CD146 (1:100) 
(Abcam, United Kingdom).  
 After several washes and a one-hour incubation with secondary conjugated antibodies, 
donkey anti-rabbit 488 and donkey anti-mouse 594, 1:500, (Invitrogen, USA), cell’s 
nuclei were counterstained with dapi (1:1000) (Sigma, USA) for 5 minutes and then 
analyzed in an Axio Imager Z1m fluorescence microscope (Zeiss, Germany). 
 
2.8 Nuclear and cytoplasmic fractionation of the cells for Western 
Blot 
HIF-1α is oxygen responsive subunit. Under regular oxygen conditions, HIF-α subunits are 
hydroxylated being fastly degraded via the von Hippel-Lindau in the proteasome through 
ubiquitination. This degradation process occurs in the cytoplasm of the cells. At lower oxygen 
conditions HIF-α subunits translocate to the nucleus where they bind to the respective 
heterodimers. Both normoxic and hypoxic conditions are being studied being, thus, important to 
separate the cytoplasmic from the nuclear fraction.   




 To delay the degradation process all the described steps were performed on ice or at 
4ºC.  
 After each time point has been reached, the medium was removed and cells were 
washed in cold PBS. Then, 150 µl of a cytoplasmic buffer composed of 50 mM of tris  
 
(Sigma, USA), 150 mM of sodium chloride (Panreac, Spain), 3 mM of magnesium 
chloride (Thermo Scientific, USA) , 1mM of dithiothreitol (Sigma, USA), 1 mM of 
ethylenediaminetetraacetic acid (Sigma, USA), 1% of triton x100 (Sigma, USA) and 
protease inhibitor cocktail (important to delay the proteasome degradation) 1:100 
(Sigma, USA), was added to the wells.  
 The lysis buffer was incubated for 10 minutes and then, cells were centrifuged at a high 
velocity (13 000 rpm) for 20 minutes allowing nuclei to sediment and the recovery of 
the supernatant which contained the cytoplasmic fraction.  
 The nuclear pellet was resuspended in 50 µl of a high saline buffer (10 mM of tris, 450 
mM of sodium chloride, 1mM of dithiothreitol, 1 mM of ethylenediaminetetraacetic 
acid and protease inhibitor cocktail 1:100) and left for incubation during 30 minutes for 
disruption of the nuclear membrane. The disrupted nuclei were recovered by a second 
high-speed centrifugation and all the cell fractions were frozen at -80ºC. 
 
2.9 Total Protein Quantification (Bicinchoninic acid assay)  
Loading the correct amount of protein for all the conditions in a western blot is extremely 
important for making viable comparisons and conclusions between them. For that, the total 
amount of protein present in a sample has to be quantified. 
The total protein quantification assay uses bicinchoninic acid for colorimetric detection of the 
protein amount contained in a cell lysate. The principle of this assay is based on the formation 
of a purple-colored product that absorbs light as 562 nm. This purple water-soluble complex is 
formed by reacting bicinchoninic acid with a Cu+ ion by chelation. 
 The quantification was performed using a bca protein assay kit (Fisher Scientific, USA).  
 Firstly, the working reagent was prepared by mixing sodium carbonate, sodium 
bicarbonate, bicinchoninic acid and sodium tartrate in sodium hydroxide with cupric 




 The reagent was left on ice and then BSA standards with concentrations ranging from 0 
to 2000 μg/ml were prepared using both cytoplasmic and nuclear buffers. Right after, 
samples were thawed and diluted in the respective buffers in a 1:6 concentration.  
 To each 25 μl of diluted sample or standard in replicates, 200 μl of working reagent 
were added per well of a 96 well-plate.  
 
 
 The plate was then left for incubation at 37º C for 30 minutes and after that period of 
time and colour development the absorbance was read in a microplate reader 
(SYNERGY HT, BIO-TEK) at 562 nm.   
 
2.10 Western Blot 
Western Blot is a technique to identify proteins present in a cell or tissue extract by binding to 
specific antibodies. Although it comprises many tasks it’s a fairly simple technique based on 
two main processes: electrophoresis and protein blotting.  Electrophoresis occurs when an 
applied electric field moves charged particles towards the opposite electrode. This process is 
dependent on the size, structure and charge of the proteins. The proteins are then transferred to a 
nitrocellulose or polyvinylidene fluoride membrane to be stained with primary and secondary 
antibodies for detecting a specific antigen. 
 
 Briefly, upon thawing and by using a 7.5% resolving gel (40% acrylamide (Bio-Rad, 
Netherlands), 1.5 M tris-HCl (Bio-Rad, Netherlands), 10% sodium dodecyl sulfate 
(SDS) (Sigma, USA), 10% ammonium persulfate (APS) (Bio-Rad, Netherlands), 
tetramethylethylenediamine (TEMED) (Bio-Rad, Netherlands) in distilled water), 50 µg 
of protein were loaded and then transferred into a nitrocellulose membrane (Bio-Rad, 
Netherlands).  
 An overnight incubation with the primary antibody mouse anti-HIF1 alpha (BD 
Biosciences, USA) 1:500 was executed. Actin was used as a loading control in a 
concentration of 1:1000.  
 After several 5 minutes washes, secondary horseradish peroxidase anti-mouse IgG 
(H+L) (Vector Laboratories, United Kingdom) was used in a 1h incubation.  
 Finally, for detection, SuperSignal West Femto Maximum Sensitivity Substrate 
(Thermo Scientific, USA) was used following manufacturer’s instructions and the 










2.11 Implantation of SVF cell sheets following a hind limb 
ischemia model 
 
All in vivo assays were performed after consent from the 3B’s Research Group Animal 
Experimentation Ethical Committee. 
The mouse hind limb ischemia model is a simple and viable attempt to address the problem of 
vascularization. Therefore, this model is a reproducible procedure that consists in the 
interruption of blood flow between two strategic points of the hind limb, through its sectioning 
for posterior implantation of cell-based devices in an attempt to reinforce or even restore the 
regular blood flux.  
 
 Firstly, 6 months-old C57BL/6 male mice (Harlan, Netherlands) mice were anesthetized 
by continuous infusion of isofluorane (VIP300, Stoelting, Ireland) and then placed in 
the supine position in the operating table.  Both hind limbs were shaved and cleaned 
with saline solution.  
 The hind limb of the animal was attached in the operating table and the area around the 
skin surface was thoroughly disinfected with betadine. All the remaining steps were 
performed under the view of a stereomicroscope (Zeiss, Germany) for an accurate 
execution of the procedure.  
 An incision of approximately 1 cm between the knee and the medial thigh was made 
and all the fat tissue surrounding the area was secluded.  
 After separating the nerve, the femoral artery and vein were occluded using double 
knots at the ends of the vessels.  
 The segment of femoral artery/vein between the distal and proximal knots was 
transected and the SVF cell sheets placed in the medial point between the occlusion 
points. All the four control animals didn’t receive any cell sheet. Six animals were used 
per condition. 






Fixed explants were processed in the spin tissue processor (STP120-2 Microm, United 
Kingdom) and embedded in paraffin (Thermo Scientific, USA) and cut (3.5 µM – thick). The 
horse serum blocking, the Avidin Biotinylated Enzyme Complex and the secondary antibody  
 
RTU biotinylated universal anti-rabbit were integrated in a VECTASTAIN Elite ABC kit while 
the components for the DAB solution were contained in a VECTASTAIN kit both from Vector 
Labs, USA.  
 The slides were placed in the automatic stainer for deparaffinization.  
 The slides were then heated near boiling in a microwave for antigen retrieval with a 
solution containing sodium citrate (10 mM sodium citrate, Fisher Scientific, USA; 
0.05% tween, Bio-Rad, Netherlands) and then washed with distilled water.  
 To block the activity of endogenous peroxidases and proteins, a 3% hydrogen peroxide 
(VWR, France) and protein blocking (horse serum) solutions were added to the slides 
for 20 minutes and 30 minutes respectively.  
 After several washing procedures, rabbit primary antibodies to human CD 31 and α-
SMA (Abcam, United Kingdom) were applied using antibody diluent solution (PBS + 5 
drops of horse serum per ml) in the desired concentrations (1:50 and 1:100, 
respectively) at 4ºC, overnight, in a chamber humidified with wet paper bed.  
 The following steps were interleaved with washing procedures with PBS-tween. The 
secondary antibody RTU biotinylated universal anti-rabbit (mouse Ig, made in horse) 
was incubated for 20 minutes followed by the Avidin Biotinylated Enzyme Complex 
solution for more 20 minutes. Then, DAB solution (5 ml of H2O + 2 drops buffer stock 
solution + 4 drops of DAB stock solution + 2 drops of hydrogen peroxide contained in 
the kit) was added to the slides following staining on the microscope.  
 The slides were then left in water for 10 minutes and then dipped two times in Mayer’s 
Hematoxylin. Finally, the slides washed again, dehydrated in ethanol 75%, ethanol 
95%, ethanol 100% and xylene and mounted with Entellan® rapid mounting medium 
for microscopy (Merck Millipore, Germany). 
2.13 In situ hybridization 
In situ hybridization (ISH) is a technique that uses a labeled DNA or RNA probe to localize a 
specific sequence in a tissue. The binding of this probe to a sequence can be then detected by 




The procedure was executed using a detection system core kit (Biogenex) according to 
manufacturer’s instructions.  
 Briefly, the tissue sections were deparaffinized and the nucleic acids retrieved by using 
a solution contained in the kit.  
 
 After several washes, a fluorescein-labelled Alu II probe (Biogenex) specific to target 
Alu sequences of human DNA, was incubated in the slides overnight at 37ºC.  
 As a way to reduce the background, peroxidase and universal protein blocking solutions 
were then added before the incubation with the biotinylated mouse anti-fluorescein 
antibody for 30 minutes.  
 In turn, the detection of this anti-fluorescein antibody was made with a second 
streptavidin-horseradish peroxidase conjugate antibody for 30 minutes. To produce a 
colorimetric reaction in the probe targets the substrate – DAB (Vector Labs, USA) – 
was incubated until adequate color development was achieved.  
 Then, finally, the slides were dipped two times in Mayer’s hematoxylin, washed 
extensively with water, de-hydrated, washed in xylene, and mounted using Entellan®.    
 
2.14 Laser Doppler 
The blood perfusion at the implantation site was assessed by Laser Doppler one hour after SVF 
cell sheets implantation and then each week up to 33 days. Blood flow in the hind limbs was 
measured with an Infrared Laser Doppler Imager (Moor Instruments, UK). Mice were 
anesthetized using a constant flux of isofluorane and placed in a supine position on a heated 
mat. After temperature stabilization, blood flow measurements were acquired. Ratios of the 
blood flow in non-affected limbs versus intervened limbs were used to assess blood flow 










3.1 Quantification of capillary-like structures in vitro 
Capillary-like structures were stained with the endothelial and hematopoietic marker CD31 and 
with CD146 for pericytes and screened with the transmitted and reflected light microscope Axio 
Imager Z1m (Zeiss, Germany). Parameters such as number of junctions, meshes, segments, 
branches and isolated segments were quantified in an angiogenesis plug-in designed for ImageJ 
1.48[128]. Several parameters can be quantified depending on the purpose but we were focused 
on the number of nodes, junctions, meshes, segments, branches and isolated segments. A node 
is a pixel with at least 3 neighbors that when fused form junctions. The spaces between two 
junctions or one junction and one extremity are called segments and branches, respectively. 
When not branched, segments are considered as isolated while when enclosing a certain area  
 
they form a mesh. An estimate of the parameters was obtained by choosing randomly 3 
representative fields in each image and calculating an average for each. 
3.2 Quantification of blood vessels in vivo 
Perfused blood vessels, which present a brown color after performing the 
immunohistochemistry, were counted manually by an operator blind to the conditions. The wall 
of the vessels and the endothelial cells were highlighted by the antibodies α-SMA and CD 31, 
respectively, in different serial cuts. 
 
4. STATISTICAL ANALYSIS 
Data are herein expressed as mean + standard deviation for all conditions with three replicates 
for each. All statistical analysis was performed on GraphPad Prism 5 (GraphPad Software, 
USA). Flow cytometry and proliferation of SVF cells was analyzed using one-way ANOVA, 
Tukey’s post-tests and Laser Doppler with two-way ANOVA, Bonferroni post-test since the 
obtained results followed a normal distribution. For non-parametric results obtained for ELISA 
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Abstract 
One of the major concerns in Tissue Engineering (TE) and Regenerative Medicine (RM) 
strategies is the lack of a proper vasculature after transplantation that allows successful 
engraftment and survival of engineered tissues and organs. In this work, we describe a strategy 
to build angiogenic cell sheets (CS) by taking advantage of the stromal vascular fraction (SVF) 
of the adipose tissue. SVF cells were obtained by enzymatic digestion of subcutaneous 
lipoaspirate and cultured in sterile 24 well plates in normoxic (pO2 = 21%) and hypoxic (pO2 = 
5%) conditions for up to 8 days in basal medium in the absence of extrinsic growth factors. The 
DNA quantification assay showed no significant proliferative differences between the 
conditions. Immunocytochemistry against CD 31 and CD 146 antibodies exposed spontaneous 
formation of a network of capillary-like structures, more developed for hypoxic conditions. 
ELISA assays revealed increased secretion of vascular endothelial growth factor (VEGF) in 
hypoxic conditions in comparison with normoxic.  Confirming this, formation of capillary-like 
structures by endothelial cells cultured in Matrigel, using conditioned media recovered from the 
SVF cultures, was more prominent for hypoxic conditions. The same conditioned media were 
used in a scratch assay where the migration of human adipose stem cells was improved for 
hypoxic conditions. Histological analysis after in vivo implantation of 8 days SVF CS in a hind 
limb ischemia murine model revealed formation of new blood vessels near the implantation site. 
Moreover, Laser Doppler results demonstrated that the blood perfusion of the injured limb after 
30 days was enhanced for the hypoxic CS group.  
Overall, SVF CS cultured in hypoxia shows promise and may represent a viable tool to promote 







Traditional strategies in TE and RM are mainly focused on the transplantation of single-cells or 
engineered tissues using 3D biodegradable matrices and cells into the injured site. The constant 
demand for effective therapeutic approaches led to the exploitation of the potentialities of 
stem/stromal cells as powerful tools for repairing lesions caused by defects, trauma or disease. 
Nevertheless, the balance between the risks and benefits of these cell-based approaches is not 
straightforward as they have limitations that often preclude the achievement of desired results. 
This comprises low anchorage of single cells at the site of interest[129], danger of exacerbated 
immunological responses to the implanted material[50] and the need for a well-orchestrated 
interplay of molecular factors demanded to create vascularization post-transplantation[130]. 
This process of vascularization is of extreme importance when considering engineered 
constructs since an abnormal supply of nutrients and oxygen often leads to their failure.  
 
The revolutionary concept of Cell Sheet Engineering (CSE) arises in this context as an attempt 
to circumvent some of these issues. This scaffold-free approach allows the recovery of cells 
with its native extracellular matrix (ECM), produced throughout its culture, as a contiguous 
sheet that can be subsequently transplanted or act as a ramp for more complex 
constructs[94,97,131,132]. Besides this non-invasive cell harvesting, this technique avoids the 
cell loss in the transplantation site and is versatile enough to allow 3D manipulations by 
superimposing CS[52]. The potential of CSE has been extensively explored and it reached 
clinical studies stage in cornea[68],esophagus[133], myocardium[98], periodontium[66] and 
cartilage[100]. In our lab, we have proposed the use of CSE to engineer tissues such as skin[92] 
and bone[93]. In the case of a thick, complex tissue such as bone it is essential to address the 
issue of vascularization to achieve the fabrication of functional tissue. Therefore, diverse 
strategies have been designed, using not only endothelial, but also  other types of cells to 
increase the vascularization of engineered constructs[134–136] such as the ones derived from 
adipose tissue[43,137,138].  
 
Adipose tissue is regarded as a privileged source of mesenchymal progenitor cells due to its 
easy accessibility and abundancy[5]. This tissue hosts mature adipocytes as well as a stromal 
vascular fraction (SVF) which comprises several cell types including fibroblasts, pre-
adipocytes, mesenchymal progenitors, endothelial and hematopoietic cells[40–42]. Due to this 
composition, the SVF of adipose tissue is regarded as highly angiogenic source [45,139,140]. 




8%)[111] the so called “physiological normoxia”[101].  Several researchers hold this low 
oxygen pressures, natural in the stem-cell niche, as beneficial in many aspects such as 
maintenance of stemness in cells[122,141], promotion of cell proliferation[119,122,141], 
enhancement of the differentiation potential[142] and induction of several crucial genes for 
glycolysis (glucose transporters and glycolytic enzymes) and formation and maturation of the 
blood vessels such as VEGF, erythropoietin, angiopoietin and platelet-derived growth 
factor[113,117] Hypoxia-inducible factors (HIFs) are the family of transcription factors 
responsible for regulating the expression of those genes, controlling cellular responses, under 
low oxygen tensions.  
 
Herein, we describe a strategy that brings together all of these concepts. CS made from SVF 
cells were cultured to hyperconfluence in normoxic and hypoxic conditions for up to 8 days in 
basal medium. Throughout the culture period, the development of capillary-like structures was 
visible in both conditions, being more prominent for cells cultured in hypoxia. Transplantation 
of SVF CS in mice, following a hind limb ischemia model resulted in enhanced restoration of 
blood flux for the condition of hypoxic implants. 
 
2. Materials and Methods 
2.1 Isolation of SVF cells 
Human adipose stromal cells were isolated from subcutaneous fat tissue obtained through 
liposuction, from Hospital da Prelada (Porto, Portugal), after patients’ (n=3) informed consent 
and under a collaboration protocol with 3B’s Research Group, approved by the ethical 
committees of both institutions. Firstly, adipose tissue was washed extensively with PBS in 
order to remove the blood fraction. Tissue digestion was then induced with a solution of 0.05% 
of collagenase type II (Sigma, USA) in PBS (Sigma Aldrich, USA), at 37ºC for 30 minutes, 
under agitation. Digested tissue was percolated through a nylon mesh strainer and was 
centrifuged at 4 ºC, 800 g for 10 minutes. After that, the supernatant was discarded and the 
obtained SVF was incubated with a red blood cells lysis buffer (154 mM of ammonium 
chloride, 10 mM of potassium bicarbonate and 0,1 mM of ethylenediaminetetraacetic acid – all 
from Sigma, USA – in distilled water) for 10 minutes at room temperature. To restore osmotic 
equilibrium, SVF was washed in α – MEM medium (Life Technologies, United Kingdom) 
supplemented with 10% FBS (Life Technologies, United Kingdom) and 1% 
antibiotic/antimycotic (Life Technologies, United Kingdom) and filtered through a 100 µm 
nylon mesh cell strainer (Life Sciences, USA). A final centrifugation yielded a pellet of red 
blood cells-free SVF and, in order to perform an accurate nucleated cell counting, 20 µl of cell 




Kingdom) and methylene blue 0.05 wt. % in H2O (Sigma Aldrich, USA). Nuclei of nucleated 
cells were stained by methylene blue allowing a clear distinction of our cells of interest. Lastly, 
2x105 nucleated cells were distributed by each 15.6 mm diameter-well of 24-well culture sterile 
plates. 
 
2.2 Culture Conditions 
Conditions of 21% (atmospheric) and 5% of oxygen were provided to the cultures. Cells were 
kept under low oxygen conditions using a hypoxia modular incubator chamber (MIC-101, 
Billups-Rothenberg, USA) which was flushed with a mixture of 5% O2, 5% CO2 and 90 % N2, 
according to the manufacturer’s instructions. The hypoxia modular incubator chamber and 
normoxic cells were placed in a humidified incubator at 37ºC and 5% CO2. Time points of 5 and 
8 days were established for collection of the medium, which was aliquoted and frozen, as well 
as cells for posterior characterization.  
 
2.3 Flow Cytometry Analysis 
Flow cytometric characterization was performed as described by the Mesenchymal and Tissue 
Stem Cell Committee of the International Society for Cellular Therapy (ISCT)[37]. In this sense, 
fluorescent-labeled primary antibodies were used for the characterization of SVF comprised CD 
105 - FITC, CD 73 - PE, CD 90 - APC, CD 45 - FITC, CD 34 - PE and CD 31 - APC (BD 
Biosciences, Germany). In addition, DRAQ5 (eBioscience, USA) was also used for nuclear 
staining, in order to discern the cells of interest from the any remaining erythrocytes and tissue 
debris (see supplemental figure 1). Flow cytometry was conducted right after isolation and after 
5 and 8 days of culture for each biological sample. The referred antibodies were added to 1x105 
cells, incubated according to manufacturer’s instructions, washed with PBS and resuspended in 
PBS with 1% of formaldehyde (Sigma, USA). Nevertheless, only 2x104 cells were used for the 
analysis conducted in a BD FACSCalibur (BD Biosciences, Belgium) using the Cyflogic 
version1.2.1 software (CyFlo Ltd, Finland).  
 
2.4 DNA quantification on lysed cells 
The selected method to quantify DNA in lysed cells (lysed by distilled water) involved the use 
of a Picogreen-based kit according to manufacturer’s instructions (Life Technologies, USA) that 
detects double strain DNA by a quantitation assay. Briefly, standards were prepared by making 
serial dilutions of the λ DNA solution in TE 1x which was in turn diluted in ultra-pure water. To 
each 100 μl of sample or standard, 100 μl of the solution 1xTE plus Picogreen reagent were 




standards and for each condition of the samples. The fluorescent intensity was read at 485/528 
nm using a microplate reader (SYNERGY HT, BIO-TEK, USA). 
 
2.5 Matrigel assay 
Additional collected conditioned media from SVF cultures used in the in vitro tests were also 
thawed and filtered with 0.22 µM strainers. The organization in capillary-like structures was 
assessed by seeding human dermal microvascular endothelial cells (HDMECs) (see protocol of 
isolation in the supplementary results) in Matrigel (Life Sciences, USA), a basement membrane 
extract. An amount of 32 µl of Matrigel was added to each well of sterile 96 well plates in a 
humidified incubator for 30 minutes. HDMECs were then seeded on the top of the formed gel in 
a density of 1.3 x 104 cells/per well and the mixture was incubated for 24h in the humidified 
incubator of the microscope at 37º C, 5% of CO2. After 24h HDMECs were stained with calcein 
(Life Technologies, USA) and micrographs were taken using an Axio Observer inverted 
Microscope with incubation (Zeiss, Germany). 
 
2.6 In vitro scratch assay 
 
Recovered conditioned media for both conditions of biological samples used for in vivo testing 
were thawed and filtered with 0.22 µM strainers. Tissue culture inserts (ibidi, Germany) were 
attached to the middle of each well of 24 sterile well-plates and 70 µl of cell suspension 
containing 3.5 x 104 hASCs/well in α-MEM medium were added to each well of the insert. After 
24h, cells were in a confluent layer and the insert was removed. All α-MEM media were 
exchanged for the corresponding conditioned ones. Cell migration was monitored in an Axio 
Observer Inverted Microscope with Incubation (Zeiss, Germany) for 24h.  
 
2.7 ELISA 
The enzyme-linked immunosorbent assay was performed with mini ELISA Developments Kits 
(Peprotech, USA) following manufacturer’s instructions. Briefly, the rabbit capture antibodies 
against VEGF, TIMP1, FGF and PDGF-BB were used to coat overnight the surface of 96 sterile 
well-plates followed by a 1h blockage of the unspecific bindings with BSA 1% (Sigma, USA). 
All steps in this test were interleaved with several washes. Conditioned media of all biological 
samples (n=3) were added to the wells (100 µl) for at least 2h. To allow specific antigen 
binding, the antibody-antigen complex was entrapped by a biotinylated antibody (2h of 
incubation). After that, the latter reacted with an avidin-horseradish peroxidase (avidin-hrp) 
conjugate, which was allowed to attach biotin for 30 minutes. Then, 100 µl of the chromogenic 




monitored every 5 in a total of 30 minutes in a microplate reader (SYNERGY HT, BIO-TEK, 
USA) and the absorbance was read at 405 nm with a wavelength correction at 650 nm. 
 
2.8 Immunocytochemistry 
Immediately after reaching each time point, SVF cells were fixed in 10% formalin (Thermo 
Scientific, USA) for 30 minutes. To achieve cellular permeabilization, cells were incubated with 
Triton X-100 (0, 2 % solution in PBS) (Sigma, USA) for 10 minutes. Cells were washed with 
PBS (3 times) and then blocked for unspecific binding of antibodies with 3% BSA (Sigma, 
USA) in PBS. The primary antibodies rabbit anti human-mouse CD 31 (1:50) and mouse anti 
human CD 146 (1:100) (Abcam, United Kingdom) were then diluted to the desired 
concentrations and an overnight incubation with the cells was performed. After several washes 
and one-hour incubation with Alexa’s secondary conjugated antibodies donkey anti-rabbit 488 
and donkey anti-mouse 594 (Invitrogen, USA), cells were counterstained with DAPI (1:1000) 
(Sigma, USA) for 5 minutes and then analyzed in an Axio Imager Z1m fluorescence microscope 
(Zeiss, Germany). 
 
2.9 Western Blot 
All the described extraction procedure was carried out on ice or at 4ºC. After each time point 
has been reached, cold PBS was added to the cells. After removing it, 150 µl of a cytoplasmic 
buffer composed of 50 mM of tris (Sigma, USA), 150 mM of sodium chloride (Panreac, Spain), 
3 mM of magnesium chloride (Thermo Scientific, USA) , 1 mM of dithiothreitol (Sigma, USA), 
1 mM of ethylenediaminetetraacetic acid (Sigma, USA), 1% of triton x100 (Sigma, USA) and 
protease inhibitor cocktail 1:100 (Sigma, USA), was added to the wells and allowed to lyse the 
cells during 10 minutes. Then, cells were centrifuged at 13 000 rpm for 20 minutes and the 
supernatant was recovered and stored at -80º C. The nuclear pellet was resuspended in 50 µl of a 
high saline buffer (10 mM of tris, 450 mM of sodium chloride, 1 mM of dithiothreitol, 1 mM of 
ethylenediaminetetraacetic acid and protease inhibitor cocktail 1:100) and left for incubation 
during 30 minutes for disruption of the nuclear membrane. A second high velocity 
centrifugation of 13 000 rpm was then performed and the nuclear extracts (supernatant) were 
left at -80ºC. Upon thawing, total protein amount was quantified using a BCA protein assay kit 
(Fisher Scientific, USA) following manufacturer’s instructions. By using a 7.5% resolving gel, 
50 µg of protein were loaded and then transferred into a nitrocellulose membrane (Bio-Rad, 
Netherlands). Primary antibody mouse anti-HIF1 alpha (BD Biosciences, USA) was then 
diluted to the desired concentration of 1:500 and the membrane was incubated overnight with it. 




(H+L) (Vector Laboratories, United Kingdom) 1:5000, was incubated with the membrane for 
1h. For detection, SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific, 
USA) was used following manufacturer’s instructions and the membrane was scanned, in order 
to create chemiluminescent images using a ChemiDoc XRS System (Bio-Rad, Netherlands) 
with Quantity One 4.2.1 (Bio-Rad, Netherlands) software. 
 
2.10 In vivo tests 
The transplantation of SVF CS from 8 days cultures in hypoxic and normoxic conditions was 
carried out following the establishment of hind limb ischemia in C57BL/6 (Harlan, Netherlands) 
male mice. Briefly, mice were anesthesized with a continuous flux of isofluorane (VIP300, 
Stoelting, Ireland). An incision of approximately 1cm was made starting on the knee towards 
the medial thigh and all the fat surrounding the area was secluded. After separating the nerve, 
the femoral artery and vein were occluded using double knots at the ends of the vessels. The 
segment of femoral artery/vein between the knots was transected and the CS placed between of 
the occlusion points. Six animals were used per SVF CS condition.  The controls were made 
with four animals that didn’t receive CS. After 1h, the animals’ hind limbs were monitored with 
laser Doppler (LDI2-IR, Moor Instruments, United Kingdom) analysis and then every week 
until 33 days post-surgery, time that corresponds to the sacrifice of the animals and recovery 
and fixation of the explants for immunohistochemistry.  
 
2.11 Immunohistochemistry 
After fixation, explants from in vivo experiments were processed in the spin tissue processor 
(STP120-2, Microm, United Kingdom), embedded in paraffin (Thermo Scientific, USA) and 
cuts of 3.5 µm were made. The sections were then dip in a sodium citrate solution (10 mM 
sodium citrate, Fisher Scientific, USA; 0.05% tween, Bio-Rad, Netherlands) and then heated 
near boiling for antigen retrieval. Non-specific peroxidase activity was inhibited during 20 
minutes with a 3% hydrogen peroxide solution (VWR, France) and protein binding using horse 
serum contained in a VECTASTAIN Elite ABC kit (Vector Labs, USA) according to 
manufacturer’s instructions. After several washes, rabbit primary antibodies to human CD 31 
and α-SMA (Abcam, United Kingdom) were diluted to the desired concentrations of 1:50 and 
1:100, respectively, and incubated with the samples at 4ºC overnight, in a humidified chamber. 
Then, a secondary antibody RTU biotinylated universal anti-rabbit (mouse Ig, made in horse) 
was applied for 20 minutes before the incubation with an Avidin Biotinylated Enzyme Complex 
(ABC) (20 minutes), both solutions contained in the VECTASTAIN kit. A DAB solution 




slides following color development on the microscope. The slides were washed, dipped two 
times in Mayer’s Hematoxylin, washed again and then de-hydrated in ethanol 75%, 95%, and 
100%, passed through xylene and mounted with Entellan® rapid mounting medium for 
microscopy (Merck Millipore, Germany). 
2.12 In situ Hybridization 
To detect cells of human origin in the explanted tissue, an in situ hybridization detection system 
core kit (Biogenex, USA) was used for detecting the human specific Alu repetitive DNA 
sequences, according to manufacturer’s instructions. Briefly, the slides were deparaffinized and 
the nucleic acids retrieved using the appropriate solution of the kit. Then, a fluorescein probe 
(Biogenex, USA) specific to detect Alu sequences was incubated in the slides overnight at 37ºC 
and blocking was made with peroxide and universal protein solutions. Immediately after, a 
secondary biotinylated mouse anti-fluorescein antibody was added to the slides for 30 minutes. 
Then, a second HRP conjugated antibody was added followed by its substrate, DAB (Vector 
Labs, USA), for color development. Lastly, the slides were dipped two times in mayer’s 
hematoxylin, washed extensively with water, de-hydrated, washed in xylene, and mounted using 
Entellan®.    
2.13 Quantification of capillary-like structures in vitro 
Stained capillary-like structures after immunocytochemistry for CD 31 and CD 146 were 
screened with a fluorescence microscope (Imager Z1m, Zeiss, Germany). An angiogenesis plug-
in was used to quantitatively analyze the formation and organization of pseudo capillary-like 
structures by endothelial cells in appropriate culture conditions for ImageJ 1.48[128]. Several 
parameters can be quantified depending on the purpose but we were focused on the number of 
nodes, junctions, meshes, segments, branches and isolated segments. A node is a pixel with at 
least 3 neighbors that when fused form junctions. The spaces between two junctions or one 
junction and one extremity are called segments and branches, respectively. When not branched 
segments are considered as isolated while when enclosing a certain area they form a mesh. By 
choosing 3 random representative fields in each image and averaging the values, all the 
parameters were estimated. 
 2.14 Quantification of blood vessels in vivo 
Neo blood vessels, which presented a brown color after performing immunohistochemistry 
against human CD 31 and smooth muscle actin, were counted manually over a maximum depth 





2.15 Statistical Analysis 
 
Data are herein expressed as mean + standard deviation for all conditions with three replicates 
for each. All statistical analysis was performed on GraphPad Prism 5: for results with a normal 






3.1 Flow Cytometry 
A gating strategy was designed by incubating cells with DRAQ 5 (supplemental figure 1), 
which allowed a clear distinction between nucleated cells (our cells of interest) and undesired 
erythrocytes and debris. SVF cells were analyzed immediately after isolation and after 5 and 8 
days of culture for both conditions. Right after isolation, the obtained cell population is quite 
heterogeneous displaying a higher percentage of cells positive for CD 34 and CD 31 (51.91 ± 
21.20 and 52.38 ± 26.14, respectively), comparatively to the ones exhibiting the well-
established mesenchymal markers CD 105, CD 73 and CD 90 (30.68 ± 21.55, 37.81 ±31.04 and 
81.43 ± 20.69, respectively). For 5 and 8 days of culture, the percentage of harvested SVF cells 
positive for mesenchymal progenitor cell markers increased substantially when compared to 
freshly-isolated cells (0 days), with almost the total amount of cells exhibiting a mesenchymal 
stem cell marker pattern. For the hematopoietic and endothelial markers (CD 34 and CD 31) the 
opposite can be noticed, with the percentage of cells expressing these markers decreasing over 
time (see figure 1).  However, no significant differences were found between the hypoxic and 
normoxic conditions. 
3.2 DNA quantification on lysed cells 
Proliferation of SVF cells under conditions of normoxia and hypoxia was evaluated through 
dsDNA quantification. Normoxic cells show marginally higher DNA content after 5 and 8 days 
of culture. However no statistical differences were found between the conditions. Also, the 






Figure 1 – a. Flow cytometry results obtained after using a gating strategy with DRAQ5 right after isolation (0 
days) and for the time points 5 and 8 days. Mesenchymal (CD 105, CD 90, CD 73) and endothelial (CD 31) and 
hematopoietic (CD 45, CD 34) markers were used. b. DNA quantification on lysed SVF cells for 5 and 8 days in 
hypoxic and normoxic conditions. DNA results showed significant differences for a p-value < 0.05 for donor 1 
between hypoxic and normoxic conditions both at 5 (***) and 8 days (***). Statistically, both flow cytometry and 
DNA quantification were analyzed using one-way ANOVA and Tukey’s post-tests. 
 
3.3 Matrigel Assay 
Angiogenic potential of media conditioned by SVF cells was assessed in a matrigel assay using 
HDMECS (see figure 2). The results show that stimulation of tube formation was greater for 
media collected from hypoxic samples, with network development and interconnection 
comparable to the ones in the angiogenic growth medium condition. Moreover, this 
development and interconnection seems to be more evident for both conditions at 5 days.  
3.4 Scratch Assay  
For assessment of the cell migration rate in vitro a scratch assay was performed with hASCs for 
measuring the ability of these cells to migrate towards an “acellular break” when incubated with 
media from the cultures. The rates of hASCs break closure are more evident at 5 days for both 






3.5 ELISA (Enzyme-linked Immunosorbent Assay) 
The results displayed in figure 2 show that the secretion of all growth factors tested in the whole 
set of conditions increased from day 5 to day 8. One major angiogenic factor, VEGF, is slightly 
over-secreted for all samples in hypoxic conditions. However, no significant differences were 
found within each biological sample between the normoxic and hypoxic conditions for the 
analyzed growth factors after statistical analysis.  
 
 
Figure 2 – a. Matrigel assay of HDMECs stained with Calcein-AM using conditioned media withdrawn from donor 
3 SVF cell culture in normoxic condition after 5 A) and 8 days C); and from hypoxic cultures after 5 B) and 8 days 
D). Controls were made with VEGF-containing endothelial cell growth medium which, as expected, stimulated the 
in vitro formation of capillary-like structures for HDMECS E) and with α-MEM that didn’t promote the same. b. 
Scratch assay performed with conditioned media from normoxic and hypoxic SVF cultures. Controls were made 
with α-MEM supplemented with 10% FBS at the beginning of the experiment a) and after 12h and 24h b) and c). 
Cell migration was assessed at 0h D) and I), 12h and 24h for media collected from 5 days normoxia D), E), F) and 
hypoxia G), H) samples  and 8 days normoxia J), K) and hypoxia L) and M) samples. c. Quantification of growth 
factors release to the medium by SVF cells assessed by ELISA, including vascular endothelial growth factor (VEGF), 
platelet-derived growth factor  (PDGF-BB), fibroblast growth factor (FGF) and tissue inhibitor of 









Performing immunocytochemistry against CD 31 and CD 146 assessed endothelial tubular 
structures formation by self-assembly of SVF cells. Endothelial cells (displayed in the images in 
green and red), together with pericytes (only red) are organized in a complex and interconnected 
capillary-like network. The structures are more developed and prominent for cells in hypoxia 
after 5 and 8 days of culture, than in normoxia culture conditions. The difference between the 
two conditions is more evident for donor 3, which presented the higher values for branching and 
segments, nodes, junctions and meshes development. On the contrary the number of isolated 
segments decreased. For this sample, higher values for nodes and junctions for 5 days hypoxic 
cells correlate well with the round-shaped morphology of the structures. In normoxic 
conditions, the low development of structures at 5 days is evidenced by the negligible values for 
segments and branches formation and the higher values for isolated segments. For the 8 days 
hypoxic cells the number of segments and meshes decreases although the values for the 
branching are almost the same, in comparison to the 5 days cells. This reflects a mature highly-
branched and interconnected network with more elongated segments as depicted in the picture. 
The decreased number of isolated segments reinforces the hypothesis that tubes were not 
organized as single and separate structures but instead were communicating with each other. For 
normoxia, the development of capillary-like structures was clearly delayed in comparison to 
hypoxia, with elongated segments appearing branched only after 8 days, albeit in lower 
numbers. 
3.7 Western Blot 
Western Blot analysis for HIF-1α was employed to analyze qualitatively the expression of this 
protein in hypoxic and normoxic conditions. As expected, the band of this ~120 kDa protein is 
more pronounced for hypoxic conditions in comparison with normoxia. HIF-1α inhibitor and 
cobalt chloride II were used as negative and positive controls, respectively. While for the 
inhibitor the band is less evident, an incubation of the cells with a chemical inducer of hypoxia, 





Figure 3 – a. Representative images after immunocytochemistry using endothelial marker CD 31 and CD 146 that 
stains pericytes in normoxic conditions after 5 A) and 8 days of culture, C) and in hypoxic after 5 B) and 8 days of 
culture D). Graphic representation of the quantification performed for all biological samples regarding the 
number of segments, isolated segments, meshes, branches, junctions and nodes, displayed as a mean ± standard 
deviation. Statistical analysis was performed using Kruskall-Wallis test and Dunn’s Multiple Comparison post-test. 
b. Western Blot analysis of the nuclear extracts of SVF cells for HIF-1α and for the loading control, actin. Hypoxia 
is presented at 1), hypoxia supplemented with HIF-1α inhibitor at 2), normoxia at 3) and cobalt chloride II 
supplementation at 4). 
 
3.8 Immunohistochemistry 
After 33 days, the animals were sacrificed and explants were performed. Immunohistochemistry 
results on the histological sections highlights neo-blood vessels formation (see figure 4). These 
neo-blood vessels, counted between the knots over a maximum depth of 300 µm from the 
implantation site by an operator blind to the conditions, were present in higher numbers after 
hypoxic CS implantation. In one animal of each condition of donor 3, blood vessel regeneration 





3.9 In situ Hybridization 
An in situ hybridization assay was performed with a specific Alu DNA probe to detect the 
presence of human cells in the explanted tissues. As evidenced by the figures, the stained nuclei 
in brown (due to DAB staining) correspond to human nuclei, enabling the assessment of their 
localization, namely near a blood vessel in the implantation site.  
 
 
Figure 4 - SVF cell sheet implantation was performed following hind limb ischemia in a murine model. a. 
Representative images of histological sections after immunohistochemistry with CD 31 marker. Black arrows 
indicate the neo blood vessels. b. Quantification of neo blood vessels manually counted by an operator blind to 
the conditions and based on CD 31 positive cells. The graph presents a mean ± standard deviation of all animals 
per condition. For statistical analysis one-way ANOVA and Tukey’s post-tests were used. c. Detection of 
transplanted human cells as SVF CS by chromogenic in situ hybridization 33 days after implantation. Black arrows 
point to them. In purple are represented cellular nuclei. 
 
3.10 Laser Doppler 
Images obtained by laser Doppler (see figure 5 D, F) show that 33 days after the surgery there is 
improved blood flux when SVF CS were implanted. As confirmed by the complementary graph 
of the perfusion of the blood vessels this improvement is greater when a cell sheet derived from 







Figure 5 – Laser Doppler results collected up to 33 days. Blood perfusion assessment shows that the animals that 
received the hypoxic cell sheet had an enhanced blood flux after 33 days. However, statistical analysis shows no 
statistical differences between normoxic and hypoxic conditions but when comparing hypoxia with the control 
for a p-value < 0.05, difference was significant for 19 days (*), 26 days (**) and 33 days (**) with Kruskall-Wallis 







The successful engraftment of engineered constructs and subsequent regeneration of most 
tissues are highly dependent on their perfusion by blood vessels. Traditional strategies in TE 
and RM involve the culture of endothelial cells to develop in vitro pre-vascularized structures, 
which in vivo, through interaction with the host's vasculature could give rise to a functional and 
well-organized network of blood vessels. Nevertheless, the process of building pre-vascularized 
in vitro constructs is often compromised by its complexity, especially when dealing with thicker 
constructs and the lack of stability of the primitive plexus that can lead to its regression and/or 
poor functionality. In our group, we reported the use of endothelial cells isolated or in combined 
action with pericytes stacked between osteogenic CS for the formation of new bone[135,143]. 
Both works highlight the potential of pre-vascularizing a construct before implantation as these 
in vitro co-cultures resulted in enhanced formation of bone tissue when comparing to osteogenic 
CS implanted alone. These results encouraged us to develop a simple but extremely valuable 
neovascularization strategy stemming from the combination of three important concepts: cell 
sheet engineering, SVF culture and hypoxic conditioning. In this sense, stromal cells from the 
vascular fraction of the adipose tissue were cultured until hyperconfluence, forming a robust 
pre-vascularized cell sheet, implanted subsequently in ischemic mice.   
Recently, scientists have been concentrating huge attention on the use of the stromal vascular 
fraction of adipose tissue for vascularization purposes, mainly due to its attractive composition: 
a heterogeneous cocktail of fibroblasts, pre-adipocytes, mesenchymal and endothelial 
progenitors and mural cells such as pericytes[40–42]. Mitchell et al. characterized 
phenotypically the cell populations derived from the enzymatic dissociation of the adipose 
tissue right after its isolation and along 5 passages[144]. For earliest stages they reported lower 
expression of the mesenchymal markers CD 105, CD 73 and CD 90 which increased overtime. 
Furthermore, the authors also noticed that SVF cells express the endothelial and hematopoietic 
markers CD 34 and CD 31, the first three times more than the latter. The same was reported by 
Miranville et. al, who divided the subpopulation CD 34+ in two subsets: the CD 34+/CD 31+ 
and CD 34+/CD 31-[138]. The isolation and culture of the CD 34+/ CD 31- subset resulted in 
an efficient differentiation of the cells towards the endothelial lineage and posterior 
revascularization in vivo when a hind limb ischemia murine assay was performed.  In agreement 
with what was described before, CS derived from the SVF of adipose tissue reached the peak of 
expression of endothelial and hematopoietic markers after the isolation, decreasing their values 
until practically the most part of the population is positive for CD 105, CD 73 and CD 90 at 5 
and 8 days. We hypothesized that the stromal populations characterized by the latter markers 
might grow faster than the subpopulations positive for both CD 34 and CD 31. Nevertheless, the 




appropriate to reduce the variability and better understand the results regarding, in particular, 
the CD 34 and CD 31 markers. The presence of positive cells for the hematopoietic marker CD 
45 decreased sharply with time, being considered even as negligible in light of what has been 
previously described[144]. 
For amplification of the angiogenic potential intrinsic to the SVF population, cells were 
submitted to continuous hypoxia, immediately after isolation. As suggested by several works in 
the literature, hypoxia triggers the HIF signaling pathway inducing biochemical and molecular 
changes that culminate with the expression of several genes associated with angiogenesis such 
as VEGF and PDGF-BB[113,114,117,145–147]. VEGF is the major responsible for the 
stimulation of neovascularization during vasculogenesis and angiogenesis and its expression is 
thought to be remarkably increased in low oxygen tensions. Secretion of angiogenic growth 
factors, assessed through ELISA, was demonstrated to be up-regulated for hypoxic conditions 
especially in the case of the VEGF. Matrigel and immunocytochemistry assays corroborate that 
hypoxic conditions stimulate cells capability to produce and release angiogenic growth factors 
due to the observed organization of cells in highly and interconnected capillary-like structures. 
Pericytes, detected by immunocytochemistry by CD 146 staining and absence of CD 31, might 
be crucial to the development and stabilization of the network of capillary-like structures 
throughout the 8 days of cell culture, as described previously in our lab[136]. In normoxic 
conditions, the presence of these tubes was also observed, although less robust. Koh et al. 
proposed that the formation of these structures might be due to a rearrangement of the 
endothelial and hematopoietic populations contained in the SVF[43]. Hence, we hypothesized 
that hypoxic conditions amplify this effect through the activation of the HIF signaling pathway 
which up-regulates angiogenic growth factors. Our western blot results, are consistent with the 
fact that hypoxic cultures are promoters of vasculature development and remodeling through 
HIF-1α regulation[113]. As expected, incubation with an inhibitor of the HIF-1α subunit 
resulted in poor accumulation in the nucleus as proved by the western blot assay and poor 
development of capillary-like structures in contrast to what is observed when cells are incubated 
with cobalt chloride, a chemical inducer of hypoxia (see supplemental figure 2). However, the 
specific role that each of the HIF subunits play in vascularization is not yet completely 
understood and more work needs to be developed in this sense.  
Another test performed to assess growth factors production was a cell migration assay. This 
kind of assay represents an attempt to mimic the migration of cells in vivo in particular 
environments, as wound healing, e. g.. The enhanced rate of migration for media collected from 
normoxic and hypoxic conditions at 5 days when comparing to the use of fresh medium might 
have a straight relation with growth factors release. At 8 days the difference between the control 




secretion to the media that may be influencing hASCs migration such as PDGF-AB, TGF-β1, 
and TNF-α, which had been shown to possess chemoattractant activity, could be performed as 
future test[148]. 
Oxygen concentrations didn’t seem to affect the proliferative rate of SVF cells throughout the 
culture period. The effect of hypoxia on the proliferation of adipose-derived stem cells in 
hypoxic conditions has been barely studied[149][119,122,141] and rarely in the case of SVF 
cells[150]. Further, as SVF cells achieved confluence before 8 days of culture, proliferation 
from 5 to 8 days is not robust. The degree of hypoxic induction is also an important factor 
influencing these results, i.e., as oxygen concentration is thought to vary between 2-8%[111] in 
the adipose tissue, therefore further studies using oxygen concentrations other than 5% need to 
be developed in order to take different conclusions. 
In vitro results propelled us to explore the angiogenic potential of our pre-vascularized CS in a 
case of induced hind limb ischemia in mice. Transplanted CS showed that improved 
neovascularization occurred on the surrounding tissues close to the cell sheet implantation site, 
especially for the hypoxic CS. Moreover, in vivo results in one animal of each condition for 
donor 3 exhibited regeneration of the transected vessels. ELISA results show that the highest 
values of VEGF secretion as well as meshes, segments, branches, junctions and nodes after 
performing immunocytochemistry were obtained for this sample. Furthermore, the percentage 
of cells expressing the CD 34/CD 31 markers reached a peak at 8 days for cells isolated from it. 
We therefore hypothesized that all of these factors combined with the visible regeneration of the 
blood vessels displayed in the pictures (see supplemental figure 3) might be a result of a higher 
angiogenic potential of this sample when comparing to the others.   
To our knowledge, the use of hypoxic SVF CS was never reported before but many other 
investigators have demonstrated the enhanced blood perfusion after transplantation of both SVF 
and human adipose-derived stem cells into ischemic sites[45,46,138,151]. This suggests that, 
clinically, hypoxic SVF CS might play promising active and protective roles against ischemia. 
Furthermore, Wittman et al. showed that the cryopreservation of SVF cells does not affect their 
viability nor the surface expression, adding to their clinical potential [137]. All of this 









The aim of the presented work was to develop highly angiogenic CS by culturing cells of the 
stromal vascular fraction (SVF) isolated from human adipose tissue in different oxygen 
conditions. Taken together, all results showed the viability of our strategy for this purpose as 
SVF cells, cultured in vitro as monolayered sheets, demonstrated high capacity of self-
assembling in capillary-like structures, more notorious in hypoxic conditions. A western blot 
analysis highlighted the presence of the subunit HIF-1α for both conditions with a more 
prominent band for hypoxic conditions. We therefore hypothesized that the enhanced 
angiogenic potential of the CS cultured in hypoxia might be correlated with the HIF pathway 
that results in the up-regulation of VEGF. Adding to our hypothesis, a matrigel assay showed 
that the tubular formations were more complex and interconnected when endothelial cells were 
cultured with hypoxic conditioned media. When implanted in mice, this SVF CS enhanced 
blood flow restoration and the formation of blood vessels after induced hind limb ischemia 
suggesting their suitability for use in clinical applications for neovascularization. This strategy 
shows the potential of hypoxic conditions and SVF CS for fabrication of highly angiogenic 
tools for TE and RM applications. Nevertheless, although being an extremely promising 
strategy, more studies need to be performed taking into account different variables: the 
concentrations of oxygen, the number of donors and the dynamics of all HIF subunits in 
vascularization. It could be also interesting to assess the interaction of SVF CS with CS built 
with cells derived from other different tissues by superimposing CS to engineer pre-





IV – ANNEX 
 
SUPPLEMENTARY RESULTS  
 
1. Gating Strategy performed for Flow Cytometry analysis   
As SVF is a heterogeneous mixture of diverse cell types including non-nucleated and nucleated 
cells. DRAQ5 binds to dsDNA and allowed us to define a gate that included the nucleated cells 
of interest, during flow cytometry analysis. Gated cells were then analyzed for the different 
surface markers while non-nucleated cells and debris were rejected from the analysis.  
 
Figure 101 - Gating strategy for nucleated cells in the SVF population, by using DRAQ5. It allowed a clear 
distinction between our cells of interest and undesired debris. 
 
2. Isolation of Human Dermal Microvascular Endothelial Cells  
Skin Samples, with adjacent adipose tissue, were collected in sterile containers with 100mL 
solution of PBS (Sigma, USA) with 10% Antibiotic/Antimycotic (AB) (Invitrogen, USA), 
transported under controlled temperature conditions and processed within 24 hours after 
collection. Skin tissue was disposed from the adjacent adipose tissue, washed with PBS, cut in 
small fragments (roughly 1cm2) and incubated overnight in Dispase (2.4 U/mL) (BD 
Biosciences, USA) at 4ºC. Dermis is a vascularized tissue therefore dermal microvascular 
endothelial cells (hDMECs) were isolated from the cellular suspension obtained prior to dermis 
enzymatic digestion with collagenase. In detail, the dispase solution in which dermis was 




minutes at 420 g. The pellet was then resuspended in Microvascular Endothelial Growth 
Medium (EGM-2 MV, Lonza, USA) and cells were plated in 0.7% gelatin (Sigma, USA) coated 
flasks. Endothelial cells exhibiting their characteristic cobblestone-like morphology and 
colonies arrangement were detected 72 hours after plating. 
 
3. Supplementations with cobalt chloride II and HIF-1α 
inhibitor 
In order to confirm our results, chemical induction and inhibition of hypoxia effects were tested. 
Under regular oxygen conditions, HIF-1α is hydroxylated on specific proline or asparagine 
residues by enzymes that demand dioxygen (O2), Fe (II) and 2-oxoglutarate, through a catalytic 
process[112]. At oxygen stress conditions, this subunit translocates into the nucleus where it 
binds to its heterodimer, the HIF-1β which is non-responsive to O2 concentrations. A chemical 
inducer of hypoxia, cobalt chloride II, was used as a positive control once it mimics the hypoxic 
effect. The action of cobalt chloride is mainly inhibitory at the hydroxylation process level, by 
displacing Fe (II) from the catalytic reaction and inducing HIF-1α accumulation. Also, an 
amidophenolic inhibitor of the HIF-1α subunit was used. This inhibitor blocks the accumulation 
of cellular HIF-1α in the nucleus, disrupting all the downstream effects of its accumulation. 
3.1 Proliferation of SVF cells 
 
Figure 112 - Proliferation of SVF cells conditioned by the HIF-1α inhibitor and cobalt chloride II assessed at day 5 
of SVF culture. No statistical differences were found between the two conditions. However, the inhibitor and 





The results displayed on the Graph show that the proliferation rate was influenced by the 
supplementation compounds, with a decrease on the DNA content. However, no statistical 
differences were found when considering the concentrations of DNA for induced hypoxia and 
HIF-1α inhibited condition. In addition, as cells were incubated from day 1 until day 5 with 
CoCl2 they might be experiencing some cytotoxicity. Several studies report that the cytotoxicity 
of cobalt chloride II over the cells is time and dose dependent[152–156]. For lower 
concentrations and exposure time cobalt chloride did not induce significant cell death but it 




Figure 123 - Immunocytochemistry against CD 31 and CD146 and quantification of capillary-like structures 
assessing HIF-1α inhibitor and cobalt chloride II effects over the cells. The lower (by HIF-1α inhibition) and higher 
(through cobalt chloride supplementation) complexities may be associated with the HIF-1 α signalling pathway. 
Although the structures were clearly more developed after the cobalt chloride supplementation, 
the quantification was not conclusive. Higher values in the counting for the cobalt chloride 
supplementation were expected as it mimics the hypoxic effect, but the poor quality of the 





4. In vivo hind limb ischemia model 
 
Figure 4 - In vivo tests were performed following a hind limb ischemia murine model. After 33 days, the animals 
were sacrificed and the explants fixed for immunohistochemistry. The image depicts the place of implantation 
after sacrifice. Inside the boxes are visible the regenerated vessels. 
In vivo results of SVF cell sheet transplantation after inducing ischemia. One animal of each 
condition for donor 3 exhibited regeneration of the transected vessels. Elisa results show that the 
highest values of VEGF secretion as well as meshes, segments, branches, junctions and nodes 
after performing immunocytochemistry were obtained for this sample. Furthermore, the 
percentage of cells expressing the CD34/CD31 markers reached a peak at 8 days for cells 
isolated from it. We therefore hypothesized that the regenerated vessels displayed in the pictures 
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